Wills Robert James — SEC insider filings

SEC reporting owner CIK 1634189. 25 insider filings on record with FilingPulse; latest filed 2026-08-24.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2020-10-05 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Alpha Cognition Inc. (ACOG)Director42 legs · 25,000 sh · $223,528—3
Oncternal Therapeutics, Inc. (ONCT)Director72 legs · 10,000 sh · $86,2571 leg · 980 sh · $8,8594
Milestone Pharmaceuticals Inc. (MIST)Director91 leg · 15,000 sh · $73,950—10
CymaBay Therapeutics, Inc. (CBAY)Director5——18

Insider filings — Wills Robert James

FiledFormIssuerReported transactionsSource
2026-08-244Alpha Cognition Inc. (ACOG)Purchase (P): 10,000 @ $9.62EDGAR
2026-06-124Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 77,000 (derivative) @ $0EDGAR
2026-01-164Alpha Cognition Inc. (ACOG)Grant/award (A): 7,241 @ $0 · Grant/award (A): 8,437 (derivative) @ $0EDGAR
2025-08-214Alpha Cognition Inc. (ACOG)Purchase (P): 15,000 @ $8.49EDGAR
2025-07-154Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 50,000 · Grant/award (A): 50,000 (derivative) · Grant/award (A): 50,000 (derivative)EDGAR
2025-06-124Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-04-094Alpha Cognition Inc. (ACOG)Grant/award (A): 30,019 (derivative) @ $0EDGAR
2024-08-294Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-244Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 2,200 (derivative) @ $0EDGAR
2024-04-104Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 3,086 @ $8.96EDGAR
2024-04-014Oncternal Therapeutics, Inc. (ONCT)Purchase (P): 6,914 @ $8.48EDGAR
2024-03-224CymaBay Therapeutics, Inc. (CBAY)Disposition to issuer (D): 30,000 · Disposition to issuer (D): 18,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 9,000 (derivative) · Disposition to issuer (D): 27,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +8 moreEDGAR
2024-02-274Oncternal Therapeutics, Inc. (ONCT)Sale (S): 980 @ $9.04EDGAR
2024-01-264CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 14,010 (derivative) @ $0EDGAR
2023-06-304Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-094Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-10-214Milestone Pharmaceuticals Inc. (MIST)Purchase (P): 15,000 @ $4.93EDGAR
2022-08-114Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2022-06-174Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2022-01-274CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 67,000 (derivative) @ $0EDGAR
2021-07-294Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2021-05-274Oncternal Therapeutics, Inc. (ONCT)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2021-01-284CymaBay Therapeutics, Inc. (CBAY)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2020-10-054Milestone Pharmaceuticals Inc. (MIST)Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1634189 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs